COMPUGEN LTD cotiza a 2.07 USD y tiene una capitalización bursátil de $196M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG an…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.07 | $-0.08 | $0.60 |
| Estimado | $-0.08 | $-0.08 | $-0.08 | $0.14 |
| Sorpresa | — | +12.5% | +0.0% | +328.6% |
| Métrica | CGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 87.3% | 57.0% | +30.3% |
| Operating Margin | 43.0% | -38.6% | +81.7% |
| Net Margin | 48.6% | -33.6% | +82.1% |
| FCF Margin | 43.0% | -13.9% | +56.9% |
| ROE | 34.4% | -40.4% | +74.8% |
| ROA | 22.6% | -32.0% | +54.6% |
| Current Ratio | 6.56 | 2.84 | +3.72 |
| Debt / Equity | — | 0.28 | — |